Tuesday, August 18, 2015

desire, thy name is . . .

Sprout Pharmaceuticals got FDA approval for its libido-boosting pill for women, called Addyi. As with many pharmaceuticals, it is controversial, in this case exposing two opposing lines of thought about the need for the drug and questions about its safety and efficacy. I'll dodge that debate. I'm not qualified to engage in it, for a multitude of reasons.

But I am qualified to engage in verbal foreplay. Or is it syllabic role-play? Anyway, is it vaguely possibly that the pharma pholks considered, and rejected, any of these names for their new product?

Attagirl

Attaboy

Loveya

Likeya

Friendme

Pantpurrgo

Screamy

Warmup

Myagra

Empowerglo

You can see why these were not selected. Suppy your own in the comments, if you dare.

(Incidentally, what do you think of Sprout Pharmaceuticals? What other industries is Sprout in? Seeds? hedge funds? fertility clinics? turf? irrigation? fertilizer? vitamins?)

p.s. The generic name is flibanserin. Play with that one, too, wordsmitherers.


No comments: